Deferasirox in Indian children with thalassemia major: 3 years experience

OBJECTIVE: To evaluate the efficacy and safety of the oral iron chelator deferasirox in treating transfusional hemosiderosis in a cohort of Indian children with thalassemia major with high iron load. MATERIALS AND METHODS: The first 50 children (age 2-18 yrs) with thalassemia major to commence defer...

Full description

Saved in:
Bibliographic Details
Main Authors: Dhamija, Mayank, Mahajan, Amita, Kalra, Manas, Virmani, Anju
Format: Artigo
Language:Inglês
Published: Medknow Publications & Media Pvt Ltd 2013
Subjects:
Original Article
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC3715972/
https://ncbi.nlm.nih.gov/pubmed/23878481
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4103/0971-5851.113407
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items